Skip to content
GenoLensGenoLens

MPIG6B

Chr 6p21.33

megakaryocyte and platelet inhibitory receptor G6b

Aliases:
G6b, NG31, G6b-B
MANE:
ENST00000649779.1

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Bleeding and platelet disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Inherited bleeding disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Cytopenia - NOT Fanconi anaemia

    BIALLELIC, autosomal or pseudoautosomal
  • Cytopenias and congenital anaemias

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • thrombocytopenia, anemia, and myelofibrosis

    0.69
  • blood platelet disease

    0.37
  • Thrombocytopenia

    0.16
  • Abnormal bleeding

    0.14
  • thrombocythemia 2

    0.13
  • hereditary disease

    0.12
  • gray platelet syndrome

    0.08
  • beta-thalassemia-X-linked thrombocytopenia syndrome

    0.07
  • Beta-thalassemia - X-linked thrombocytopenia

    0.07
  • acute erythroid leukemia

    0.06

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Megakaryocyte and platelet inhibitory receptor G6b

Inhibitory receptor that acts as a critical regulator of hematopoietic lineage differentiation, megakaryocyte function and platelet production (PubMed:12665801, PubMed:17311996, PubMed:27743390). Inhibits platelet aggregation and activation by agonists such as ADP and collagen-related peptide (PubMed:12665801). This regulation of megakaryocate function as well as platelet production ann activation is done through the inhibition (via the 2 ITIM motifs) of the receptors CLEC1B and GP6:FcRgamma signaling (PubMed:17311996). Appears to operate in a calcium-independent manner (PubMed:12665801)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.